| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP,Clinical &Medical Affairs
1 company
Hogge Gary S. is a SVP,Clinical &Medical Affairs at Lineage Cell Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $17K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2021 | LCTX Lineage Cell Therapeutics, Inc. | SVP,Clinical &Medical Affairs | Sale+OE | 539,283 | $2.45 | $1,321,328.90 | -90.5% | -37.9% | -49.0% |